ADAMA Delivers First Quarter Business Growth Despite COVID-19
pandemic
USD sales and profits impacted by significant pandemic-related global currency
weakness
Q1 Sales of $973 million, up 2% at constant exchange rates, lower by 3% in US dollar
terms
Solid business growth seen in Latin America and the India, Middle East & Africa region, while
Europe also grew in local currency terms despite softer pricing environment
Constant currency sales constrained by an estimated $47 million due to COVID-19 pandemic
In US dollar terms, sales were impacted by a further $50 million due to the widespread
depreciation of currencies, most notably the Brazilian Real, Euro and the Australian dollar,
resulting from the pandemic amongst other factors
Q1 EBITDA of $142 million; impacted by $34 million in currency headwinds
Material global currency headwinds, together with pricing pressures, mainly in Europe and
China, alongside continued supply-related pressure on procurement costs, posed significant
challenge to margins
COVID-19 pandemic constrained Q1 EBITDA by an estimated $20 million, in addition to
currency headwinds
Continued tight control of operating expenses delivered material savings, despite inclusion of
recent acquisitions as well as idleness from temporary suspension of Jingzhou site due to
coronavirus outbreak in Hubei province
Q1 Net Income of $27 million, reflecting $62 million impact of global currency weakness
Significant global currency weakness against the US dollar, especially of the Brazilian Real,
adding $29 million to tax expenses
COVID-19 pandemic constrained Q1 Net Income by an estimated $17 million, in addition to
the $62 million currency impact
BEIJING, CHINA and TEL AVIV, ISRAEL, April 27, 2020 – ADAMA Ltd. (the “Company”) (SZSE
000553), today reported its financial results for the first quarter ended March 31, 2020.
During the first quarter of 2020, the global agrochemical market, amongst many others, was
impacted by the unprecedented coronavirus pandemic, COVID-19. The pandemic, which started
early in the quarter and now continues to rage throughout the rest of the world, has had a number of
adverse effects on ADAMA’s performance in the first quarter, the most significant of which were:
In China, while operations at the Company’s Huai’An, Jiangsu site have continued without
material interruption, operations at the Jingzhou site in Hubei province were temporarily
suspended from late January until the end of February due to the coronavirus outbreak in the
province. Although operations at the site recommenced at the beginning of March, restrictions
on logistics remained, impacting the free transport of goods to and from the sites and to the
ports;
Renewed tightening in supply of raw materials and intermediates sourced from third parties in
China and around the world;
Restrictions on international trading and sales through the Company’s global channels, as well
as increased costs of global shipping, airfreight and other logistics;
1
Lower demand in the Company’s US Consumer & Professional (non-crop) businesses, as
retailers slowed their restocking of products due to the coronavirus outbreak;
Significant impacts on global currency markets, which have seen the rapid depreciation of many
currencies against the US dollar, most notably the Brazilian Real, Australian dollar, Turkish Lira
and Indian Rupee, as well as increased volatility in the Euro. These movements have negatively
impacted the Company’s performance in the first quarter compared to the corresponding period
last year.
The ongoing spread of the pandemic is expected to continue to negatively impact the performance
of the Company in the second quarter, and potentially beyond. The Company is actively managing
its response to the outbreak in order to ensure the safety of its employees and limit the impact on
the Company’s performance. Actions being taken include extending and strengthening distribution
channels, use of expedited transport options where possible, working collaboratively with supply
chain partners, and raising prices wherever possible to accommodate the weaker currencies and
increased logistics costs.
Ignacio Dominguez, President and CEO of ADAMA, said, “Our resilient performance and
continued business growth in the quarter was achieved in the face of the unprecedented coronavirus
pandemic, which is significantly changing the way we live our lives, while also causing major
disruption to global trade, including the currency markets, amongst many others. During this
troubling and uncertain period, I am very proud of the response of our teams across the globe to
ensure the health and safety of our employees, and mitigate the impact of the pandemic on our
business.”
Table 1. Financial Performance Summary
% %
Currency
Adjusted, US$ millions Q1 2020 Q1 2019 Change Change
Impact
CER USD
Revenues 973 1,006 +1.6% -50 -3.4%
Gross profit 289 344 -4.8% -39 -16.0%
Gross margin 29.7% 34.2%
Operating income (EBIT) 82 127 -8.4% -34 -35.4%
EBIT margin 8.4% 12.6%
Net income 27 80 -62 -66.3%
Net income margin 2.8% 8.0%
EBITDA 142 187 -6.1% -34 -24.1%
EBITDA margin 14.6% 18.6%
Earnings per share – USD 0.0110 0.0327
– RMB 0.0766 0.2207
CER: Constant Exchange Rates
All income statement items contained in this release are presented on an adjusted basis. A detailed description and
analysis of differences between the adjusted income statement and that reported in the financial statements is contained in
the “Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements” in the
appendix to this release. EPS are the same for basic and diluted.
Financial Highlights
2
Revenues in the first quarter were $973 million, up 2% at constant exchange rates, with continued
business growth in the face of the COVID-19 pandemic. Constant currency sales were constrained
by an estimated $47 million due to the COVID-19 pandemic. In addition, sales were heavily
impacted by the depreciation of global currencies, resulting in sales in US dollar terms being 3%
below those of the same period last year.
The Company delivered solid business growth in Europe, driven by a strong performance in Eastern
European countries, as well as throughout the India, Middle East & Africa region supported by
favorable weather conditions in key areas. In Latin America, the Company has grown its sales in
constant currency terms, strengthened by its recent acquisition in Peru, but sales in US dollar terms
were impacted by the depreciation of regional currencies, most notably the Brazilian Real. Sales in
North America were lower largely due to the impact of the coronavirus on demand for the
Company’s Consumer & Professional products. In Asia-Pacific (excluding China), a strong
performance in Australia, which has begun to see a recovery from the extreme drought conditions of
the past few years, largely compensated for a coronavirus-driven slowdown in East-Asian markets
and the depreciation of local currencies.
In China, despite seeing continued growth in the sales of the Company’s branded, formulated
products, overall sales in the country were impacted by lower sales of intermediates and
unformulated products, mainly those produced at the Jingzhou site which was temporarily
suspended during the quarter.
Gross profit in the first quarter was $289 million (gross margin of 29.7%), compared to $344 million
(gross margin of 34.2%) in the corresponding period last year. The lower gross margin was mainly a
result of the material depreciation of global currencies, alongside some pricing pressure, mainly in
Europe and China, and sustained high procurement costs, all of which were only partially offset by
the business growth achieved in the quarter.
Operating expenses. Total operating expenses in the first quarter were $207 million (21.2% of
sales), compared to $218 million (21.6% of sales) in the corresponding period last year. The
Company continues to exercise tight control of its operating expenses, assisted by the beneficial
impact of the strengthening of the US dollar against global currencies, achieving significant savings
even while including companies acquired during 2019. The first quarter this year also saw the
recording of Jingzhou-related idleness costs resulting from the temporary suspension of operations
there due to the coronavirus outbreak in an amount similar to those recorded also during Q1 2019
when the sites were similarly suspended, while the first quarter last year also benefited from income
related to expropriation of land.
Operating income in the quarter was $82 million (8.4% of sales), compared to $127 million (12.6%
of sales) in the corresponding period last year. The widespread currency depreciation, due to the
coronavirus outbreak among other factors, constrained operating income by $34 million in the
quarter.
EBITDA in the quarter was $142 million (14.6% of sales), compared to $187 million (18.6% of sales)
recorded in the corresponding period last year. The lower EBITDA in the quarter was driven by the
lower gross profit, which was partially offset by the reduction in operating expenses. The COVID-19
pandemic constrained Q1 EBITDA by an estimated $20 million, in addition to the $34 million in
currency headwinds due, amongst other factors, to the coronavirus outbreak.
Financial expenses and investment income. Total net financial expenses and investment income
were $31 million in the first quarter, compared to $37 million in the corresponding period last year.
The lower financial expenses in the quarter reflect financial income earned due to the effect of the
appreciation of the US dollar against the RMB on the value of US dollar-denominated monetary
3
assets in China, while the higher expenses in the prior year resulted from the opposite. This financial
income in the quarter more than offset the slightly increased interest costs on higher net debt levels.
Tax expenses. Net tax expenses were $24 million in the first quarter, compared to $9 million in the
corresponding period last year. The higher expense was largely due to the impact of weakening of
currencies against the US dollar, most notably that of the Brazilian Real, driving higher non-cash tax
expenses due to differences between the functional (US dollar) and tax (local) currencies regarding
the value of non-monetary assets.
Net income in the first quarter was $27 million (2.8% of sales) compared to $80 million (8.0% of
sales) recorded in the corresponding period last year, reflecting the lower operating income and
higher tax expenses. The COVID-19 pandemic constrained Q1 Net Income by an estimated $17
million, in addition to the $62 million impact of global currency movements.
Trade working capital at March 31, 2020 was $2,178 million, compared to $2,082 million at the
same point last year. The slightly higher level reflects higher trade receivables and lower trade
payables, which were partially offset by lower inventory levels. The higher trade receivables were
driven largely by the Company’s strong growth over the last year in Latin America, especially Brazil,
where customer credit terms are generally longer. Although trade payables were somewhat lower in
comparison to their levels a year ago, they were significantly improved over the course of the quarter,
contributing to the improvement in operating cash flow.
Cash Flow. Operating cash flow of $55 million was consumed in the first quarter, compared to $191
million consumed in the corresponding period last year. The improved operating cash flow in the
quarter mainly reflects the improvement in working capital during the quarter compared to the
parallel period last year.
Net cash used in investing activities was $53 million in the first quarter, compared to $159 million in
the corresponding period last year which included the acquisition of Bonide.
Free cash flow of $116 million was consumed in the first quarter compared to $355 million
consumed in the same period last year, reflecting the improvement in operating cash flow in the first
quarter of this year, contrasted with the higher investment levels and acquisitions of the same period
in 2019.
Leverage: Balance sheet net debt at March 31, 2020 stood at $1,189 million, compared to $875
million as at March 31, 2019, largely reflecting the 2019 acquisitions and the assumption of their
debt, as well as capital investments in portfolio expansion and the Company’s other growth engines.
Regional Sales Performance
Q1 2020 Q1 2019 Change Change
$m $m CER USD
Europe 357 360 +2.7% -1.0%
North America 168 180 -6.0% -6.7%
Latin America 159 159 +12.5% -0.3%
Asia Pacific 158 186 -9.8% -14.9%
Of which, China 68 94 -24.6% -27.1%
India, Middle East & Africa 131 121 +12.5% +8.3%
4
Total 973 1,006 +1.6% -3.4%
CER: Constant Exchange Rates
Europe: Sales increased by 2.7% in the first quarter at constant exchange rates, compared with
the corresponding period last year, driven by continued business growth, partially offset by lower
prices resulting from high inventory levels in the industry’s distribution channels.
In Northern Europe, ADAMA saw pleasing business growth in the quarter, partially recovering from
supply constraints seen in 2019 that affected key products. The Company delivered robust growth
in most Eastern European countries supported by favorable weather conditions, with noteworthy
performances recorded in Russia and Ukraine, where the Company is seeing continued market
share gains, as well as Hungary and Romania, which benefited from an early start to the 2020
season. In addition, the Company grew in the key western European markets of France and Italy.
In US dollar terms, sales in Europe were lower by 1.0% in the quarter, compared to the
corresponding period last year, reflecting the net impact of weaker currencies, largely due to the
coronavirus outbreak.
North America: Sales in the quarter were lower by 6.0%, at constant exchange rates, compared to
the corresponding period last year, largely due to the impact of the coronavirus which reduced
demand for the Company’s Consumer & Professional (non-crop) products.
The Company recorded strong business growth in Canada with solid demand for crop protection
products, as well as favorable weather conditions. In the US, ADAMA obtained two new rice
herbicide registrations in the quarter, enhancing its portfolio of solutions for conventional rice and
complementing ADAMA’s Preface and Postscript herbicides for the FullPage Rice Cropping
Solution, furthering the Company’s offering to rice farmers.
In US dollar terms, sales in North America were lower by 6.7% in the quarter, compared to the
corresponding period last year, reflecting the coronavirus-related weakening of the Canadian
Dollar.
Latin America: Sales grew by 12.5% in the first quarter, at constant exchange rates, compared to
the corresponding period last year. The robust performance was driven by strong business growth,
bolstered by the Company’s recent acquisition in Peru, alongside continued price increases.
The Company saw continued constant-currency business growth in Brazil in the quarter, despite
drought conditions which delayed the planting season in key crops including soybean and reduced
application of fungicides. Noteworthy performances were also recorded in the quarter in Mexico,
benefiting from good weather conditions particularly in the Pacific region, as well as Colombia and
Ecuador, driven by a good harvest season in key crops.
ADAMA continues to expand its differentiated product offering in the region with the launch during
the quarter of EMINENT, a dual mode broad-spectrum insecticide, in Argentina. The Company
also obtained the registration of UBERTOP, an insecticide used mainly for the control of a wide
range of pests in tomato and cabbage, in Mexico.
In US dollar terms, sales in Latin America were lower by 0.3% in the quarter, compared to the
corresponding period last year, reflecting the significant depreciation of regional currencies, most
notably the Brazilian Real, as a result of the coronavirus outbreak.
Asia-Pacific: Sales were lower by 9.8% in the quarter, at constant exchange rates, compared to
the corresponding period last year, due largely to the outbreak of the COVID-19 pandemic, which
started early in the quarter.
5
In Asia-Pacific (excluding China), a strong performance in Australia, which has begun to see a
recovery from the extreme drought conditions of the past few years, largely compensated for a
coronavirus-driven slowdown in East-Asian markets. In China, despite seeing continued growth in
the sales of the Company’s branded, formulated products, overall sales in the country were
impacted by the coronavirus outbreak which resulted in logistics and supply challenges, and
reduced sales of intermediates and unformulated products from the temporarily suspended
Jingzhou site.
During the quarter, the Company launched new products including QUALIPRO ENCLAVE, a
quadruple-mode of action fungicide mixture for use in turf in Australia, and obtained multiple new
product registrations in the region, including BALORIC and SOLITO, an early post-emergence
rice herbicide, in Thailand and Indonesia.
In US dollar terms, sales in Asia-Pacific were lower by 14.9% in the quarter, compared to the
corresponding period last year, reflecting the impact of weaker currencies following the coronavirus
outbreak.
India, Middle East & Africa: Sales in the first quarter grew by 12.5%, at constant exchange rates,
compared to the corresponding period last year. The Company recorded robust business growth in
all major markets throughout the region, alongside increased prices, despite the impact of the
missing sales of Jingzhou old site products resulting from the temporary suspension of operations
there due to the coronavirus outbreak.
ADAMA delivered solid business growth in India combined with higher pricing, in spite of a
countrywide lockdown enforced by the Indian government that commenced towards the end of the
quarter. The Company also grew strongly in South Africa and Israel, benefiting from favorable
weather conditions, and delivered pleasing results in Turkey from where the Company is also
expanding its presence into surrounding countries in the region.
In US dollar terms, sales in the region grew by 8.3% in the quarter, compared to the corresponding
period last year, reflecting the impact of softer currencies, which were adversely affected by the
coronavirus outbreak, most notably the Turkish Lira and the Indian Rupee.
2017 ADAMA-Sanonda Combination: Value Adjustment Mechanism
Within the context of the 2017 combination between Hubei Sanonda Co. Ltd. (“Sanonda”, as it was
then known) and Adama Agricultural Solutions Ltd. (“Solutions”), the Company entered into a
Performance Compensation Agreement with CNAC, then the 100% owner of Solutions and the
controlling shareholder of Sanonda. Under this agreement, CNAC made a commitment regarding
Solutions’ aggregate net profit in 2017, 2018 and 2019. In case of failure to meet the commitment,
CNAC is required to compensate the Company either through shares or cash according to a
predetermined formula. The aggregate net profit commitment for the 2017-2019 period, as agreed
to by CNAC, was an amount of $543.4 million. Despite Solutions’ strong performance during the
three-year period, due to exogenous reasons, the calculated net profit of Solutions for this period
has now been determined to be approximately $512.7 million, implying a shortfall of approximately
$30.7 million. This shortfall was caused entirely by the impact of the Divestment & Transfer of
several products that Solutions implemented to facilitate the approval by the EU Commission of the
acquisition of Syngenta by ChemChina, which caused an aggregate of $66 million in incremental
non-cash amortization charges related to the written-up value of the assets received from
Syngenta. Absent these non-cash amortization charges, Solutions would have exceeded the profit
commitment by approximately $35 million.
As a result, CNAC will be required to return to the Company 102,432,280 out of the 1,810,883,039
shares it received in the Company in exchange for the transfer of 100% of Solutions to the
Company in 2017, and return the relevant portion of the dividends it received in respect of such
6
shares. Following their receipt, these shares will be canceled by the Company. As a result, the
total number of shares in issue will be reduced to 2,344,121,302, and CNAC’s aggregate
ownership in the Company will reduce from 78.9% to 78.0%.
In addition to the profit commitment, and as required by the relevant regulation, an independent
valuation of Solutions’ has been performed in order to assess any potential diminution in the value
of Solutions. Following the performance of such valuation, it has been determined that no such
diminution has occurred.
Revenues by operating segment
First quarter sales by segment
Q1 2020 Q1 2019
% %
USD(m) USD(m)
Crop Protection 885 91.0% 910 90.4%
Intermediates and Ingredients 88 9.0% 97 9.6%
Total 973 100.0% 1,006 100.0%
First quarter sales by product category
Q1 2020 Q1 2019
% %
USD(m) USD(m)
Herbicides 441 45.3% 458 45.5%
Insecticides 217 22.3% 268 26.6%
Fungicides 227 23.3% 184 18.3%
Intermediates and Ingredients 88 9.0% 97 9.6%
Total 973 100.0% 1,006 100.0%
Note: the sales split per product category is provided for convenience purposes only, and is not representative of the way the Company
is managed or in which it makes its operational decisions.
Further Information
All filings of the Company, together with a presentation of the key financial highlights of the period,
can be accessed through the Company website at www.adama.com.
##
About ADAMA
ADAMA Ltd. is a global leader in crop protection, providing solutions to farmers across the world to
combat weeds, insects and disease. ADAMA has one of the widest and most diverse portfolios of
active ingredients in the world, state-of-the art R&D, manufacturing and formulation facilities,
together with a culture that empowers our people in markets around the world to listen to farmers
and ideate from the field. This uniquely positions ADAMA to offer a vast array of distinctive
mixtures, formulations and high-quality differentiated products, delivering solutions that meet local
farmer and customer needs in over 100 countries globally. For more information, visit us at
www.ADAMA.com and follow us on Twitter at @ADAMAAgri.
7
Contact
Ben Cohen Zhujun Wang
Global Investor Relations China Investor Relations
Email: ir@adama.com Email: irchina@adama.com
8
Abridged Consolidated Financial Statements
The following abridged consolidated financial statements and notes have been prepared as
described in Note 1. While prepared based on the principles of PRC GAAP, they do not contain all
of the information which either PRC GAAP or IFRS would require for a complete set of financial
statements and should be read in conjunction with the consolidated financial statements of both
ADAMA Ltd. and Adama Agricultural Solutions Ltd. as filed with the Shenzhen and Tel Aviv Stock
Exchanges, respectively.
Abridged Consolidated Income Statement for the First Quarter
Q1 2020 Q1 2019 Q1 2020 Q1 2019
Adjusted1
USD(m) USD(m) RMB(m) RMB(m)
Revenues 973 1,006 6,782 6,788
Cost of Sales 681 659 4,750 4,442
Business taxes and surcharges 3 4 19 25
Gross profit 289 344 2,013 2,321
% of revenue 29.7% 34.2% 29.7% 34.2%
Selling & Distribution expenses 159 164 1,106 1,103
General & Administrative expenses 28 32 194 217
Research & Development expenses 13 14 92 96
Other 7 8 48 52
Total operating expenses 207 218 1,440 1,468
% of revenue 21.2% 21.6% 21.2% 21.6%
Operating income (EBIT) 82 127 573 853
% of revenue 8.4% 12.6% 8.4% 12.6%
Financial expenses and investment income 31 37 217 252
Income before taxes 51 89 356 601
Taxes on Income 24 9 169 61
Net income 27 80 187 540
% of revenue 2.8% 8.0% 2.8% 8.0%
EBITDA 142 187 993 1,264
% of revenue 14.6% 18.6% 14.6% 18.6%
Earnings per Share – Basic 0.0110 0.0327 0.0766 0.2207
– Diluted 0.0110 0.0327 0.0766 0.2207
The number of shares used to calculate both basic and diluted earnings per share is 2,446.6 million shares.
1
For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the
financial statements, see below “Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements”.
9
Abridged Consolidated Balance Sheet
March 31 March 31 March 31 March 31
2020 2019 2020 2019
USD (m) USD (m) RMB (m) RMB (m)
Assets
Current assets:
Cash at bank and on hand 602 713 4,264 4,801
Bills and accounts receivable 1,414 1,344 10,019 9,052
Inventories 1,424 1,482 10,091 9,979
Other current assets, receivables and
461 290 3,264 1,949
prepaid expenses
Total current assets 3,901 3,829 27,638 25,781
Non-current assets:
Fixed assets, net 1,099 1,134 7,786 7,637
Rights of use assets 75 79 534 534
Intangible assets, net 1,455 1,497 10,308 10,077
Deferred tax assets 118 119 833 801
Other non-current assets 96 100 681 674
Total non-current assets 2,843 2,929 20,142 19,723
Total assets 6,744 6,758 47,780 45,504
Liabilities
Current liabilities:
Loans and credit from banks and
507 390 3,595 2,627
other lenders
Bills and accounts payable 680 767 4,814 5,163
Other current liabilities 813 796 5,760 5,358
Total current liabilities 2,000 1,953 14,169 13,148
Long-term liabilities:
Long-term loans from banks and other
167 70 1,181 472
lenders
Debentures 1,101 1,147 7,804 7,723
Deferred tax liabilities 63 56 448 380
Employee benefits 97 87 687 588
Other long-term liabilities 140 141 991 950
Total long-term liabilities 1,568 1,501 11,111 10,113
Total liabilities 3,568 3,454 25,280 23,261
Equity
Total equity 3,176 3,304 22,500 22,243
Total equity 3,176 3,304 22,500 22,243
Total liabilities and equity 6,744 6,758 47,780 45,504
10
Abridged Consolidated Cash Flow Statement for the First Quarter
Q1 2020 Q1 2019 Q1 2020 Q1 2019
USD (m) USD (m) RMB (m) RMB (m)
Cash flow from operating activities:
Cash flow from operating activities -55 -191 -385 -1,232
Cash flow from operating activities -55 -191 -385 -1,232
Investing activities:
Acquisitions of fixed and intangible assets -51 -43 -357 -321
Proceeds from disposal of fixed and intangible assets 1 5 9 31
Acquisition of subsidiaries - -122 - -825
Other investing activities -3 1 -25 10
Cash flow used for investing activities -53 -159 -373 -1,105
Financing activities:
Receipt of loans from banks and other lenders 171 228 1,194 1,358
Repayment of loans from banks and other lenders -61 -38 -429 -110
Other financing activities -20 -66 -136 -426
Cash flow from (used for) financing activities 90 124 629 823
Effects of exchange rate movement on cash and cash -3 5 47 -78
equivalents
Net change in cash and cash equivalents -21 -221 -82 -1,593
Cash and cash equivalents at the beginning of the period 619 925 4,320 6,043
Cash and cash equivalents at the end of the period 598 704 4,238 4,450
Free Cash Flow -116 -355 -805 -2,394
Free Cash Flow excl. acquisitions -116 -232 -805 -1,569
11
Notes to Abridged Consolidated Financial Statements
Note 1: Basis of preparation
Basis of presentation and accounting policies: The abridged consolidated financial statements for the
quarters ended March 31, 2020 and 2019 incorporate the financial statements of ADAMA Ltd. and of all of its
subsidiaries (the “Company”), including Adama Agricultural Solutions Ltd. (“Solutions”) and its subsidiaries.
The Company has adopted the Accounting Standards for Business Enterprises issued by the Ministry of
Finance (the "MoF") and the implementation guidance, interpretations and other relevant provisions issued or
revised subsequently by the MoF (collectively referred to as "CASBE").
The abridged consolidated financial statements contained in this release are presented in both Chinese
Renminbi (RMB), as the Company’s shares are traded on the Shenzhen Stock Exchange, as well as in United
States dollars ($) as this is the major currency in which the Company’s business is conducted. For the
purposes of this release, a customary convenience translation has been used for the translation from RMB to
US dollars, with Income Statement and Cash Flow items being translated using the quarterly average
exchange rate, and Balance Sheet items being translated using the exchange rate at the end of the period.
The preparation of financial statements requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements, and the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimated.
Note 2: Abridged Financial Statements
For ease of use, the Financial Statements shown in this release have been abridged as follows:
Abridged Consolidated Income Statement:
“Operating expenses” includes selling and distribution expenses; general and administrative expenses;
research and development expenses; impairment losses; gain (loss) from disposal of assets and non-
operating income and expenses
“Financial expenses and investment income” includes net financing expenses; gains from changes in
fair value; and investment income (including share of income of equity accounted investees)
Abridged Consolidated Balance Sheet:
“Other current assets, receivables and prepaid expenses” includes financial assets held for trading;
financial assets in respect of derivatives; prepayments; other receivables; and other current assets
“Fixed assets, net” includes fixed assets and construction in progress
“Intangible assets, net” includes intangible assets and goodwill
“Other non-current assets” includes other equity investments; long-term equity investments; long-term
receivables; investment property; and other non-current assets
“Loans and credit from banks and other lenders” includes short-term loans and non-current liabilities
due within one year
“Other current liabilities” includes financial liabilities in respect of derivatives; payables for employee
benefits, taxes, interest, dividends and others; advances from customers and other current liabilities
“Other long-term liabilities” includes long-term payables, provisions, deferred income and other non-
current liabilities
12
Analysis of Gaps between Adjusted Income Statement and Reported
Income Statement in Financial Statements
Q1 Adjusted Adjustments Reported
USD(m) Q1 2020 Q1 2019 Q1 2020 Q1 2019 Q1 2020 Q1 2019
Revenues 973 1,006 - - 973 1,006
Gross profit 289 344 1 1 288 343
Operating expenses 207 218 -30 -29 237 247
Operating income (EBIT) 82 127 31 30 51 97
Income before taxes 51 89 31 28 20 61
Net income 27 80 29 26 -2 54
EBITDA 142 187 9 5 133 183
Earnings per share 0.0110 0.0327 -0.0010 0.0222
Q1 Adjusted Adjustments Reported
RMB(m) Q1 2020 Q1 2019 Q1 2020 Q1 2019 Q1 2020 Q1 2019
Revenues 6,782 6,788 - - 6,782 6,788
Gross profit 2,013 2,321 7 7 2,006 2,314
Operating expenses 1,440 1,468 -212 -195 1,652 1,663
Operating income (EBIT) 573 853 219 202 354 651
Income before taxes 356 601 219 186 137 415
Net income 187 540 204 173 -17 367
EBITDA 993 1,264 65 32 928 1,232
Earnings per share 0.0766 0.2207 -0.0068 0.1499
13
Income Statement Adjustments
Q1 2020 Q1 2019 Q1 2020 Q1 2019
USD (m) USD (m) RMB (m) RMB (m)
Net Income (Reported) -2.4 54.4 -16.7 366.8
Adjustments to COGS & Operating Expenses:
1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non- 11.5 11.5 79.9 77.2
cash)
2. Amortization of Transfer assets received and written-up due to 2017 7.9 10.6 54.9 71.7
ChemChina-Syngenta transaction (non-cash)
3. China Relocation & Upgrade related costs 0.9 2.3 6.3 15.5
4. Long-term incentive (non-cash) 0.7 4.7 5.1 31.9
5. Amortization of acquisition-related PPA (non-cash) 1.8 0.9 12.9 6.1
6. Employee early retirement expenses 8.6 - 59.8 -
Total Adjustments to Operating Income (EBIT) 31.4 30.0 218.9 202.4
Total Adjustments to EBITDA 9.3 4.7 64.9 31.9
Adjustments to Financing Expenses:
7. Revaluation of non-cash adjustment related to non-controlling - -2.4 - -16.1
interest
Total Adjustments to Income before Taxes 31.4 27.6 218.9 186.3
Adjustments to Taxes
1. Tax shield on Legacy PPA of 2011 acquisition of Solutions -1.9 -1.9 -13.6 -13.1
5. Deferred tax due to PPA -0.2 - 1.1 -
Total adjustments to Net Income 29.3 25.7 204.1 173.2
Net Income (Adjusted) 26.9 80.1 187.5 540.0
Notes:
1. Amortization of Legacy PPA of 2011 acquisition of Solutions (non-cash): Under PRC GAAP, the Company has inherited the historical
“legacy” amortization charge from the first combined reporting for Q3 2017 that ChemChina previously was incurring in respect of its acquisition
of Solutions in 2011. This amortization is done in a linear manner on a quarterly basis, most of which will be completed and removed in the
second half of 2020.
2. Amortization of Transfer assets received and written-up due to 2017 ChemChina-Syngenta transaction (non-cash): The proceeds from
the Divestment of crop protection products in connection with the approval by the EU Commission of the acquisition of Syngenta by
ChemChina, net of taxes and transaction expenses, were paid to Syngenta in return for the transfer of a portfolio of products in Europe of
similar nature and economic value. Since the products acquired from Syngenta are of the same nature and with the same net economic value
as those divested, and since in 2018 the Company excluded the one-time gain that it made on the divested products, the additional
amortization charge incurred due to the written-up of the acquired assets is also excluded to present a consistent view of Divestment and
Transfer transactions, which had no net impact on the underlying economic performance of the Company.
3. China Relocation & Upgrade related costs: These are non-cash accelerated depreciation charges related to the three-year Relocation &
Upgrade program in China. Production assets located in the old production sites in Jingzhou and Huai’An will be relocated to the new sites in
the coming years. Since some of the older production assets may not be able to be relocated, their economic life has been shortened and
therefore will be depreciated over a shorter period. Since these are older assets that were built many years ago and will be replaced by newer
production facilities at the new sites, and since the ongoing operations of the business will not be impacted thereby, the Company adjusts for
the impact of the accelerated depreciation of these assets.
4. Long-term Incentive (non-cash): The Company granted its employees, who are mainly non-Chinese residents, a long-term incentive (LTI) in
the form of 'phantom' options, due to the complexity of granting Chinese-listed, equity-settled options to non-Chinese employees. As such, the
Company records an expense, or recognizes income, depending on the fluctuation in the Company’s share price, even though the Company
will not incur any cash impact prior to exercise of the phantom options. To neutralize the impact of such share price movements on the
measurement of the Company’s performance and expected employee compensation and to reflect the existing phantom options, in the
Company’s adjusted financial performance, the LTI is presented on an equity-settled basis in accordance with the value of the existing plan at
the grant date.
5. Amortization of acquisition-related PPA (non-cash): Related to the amortization of non-cash intangible assets created as part of the
allocation of the purchase price (PPA) on acquisitions; has no impact on the ongoing performance of the companies acquired.
6. Employee early retirement expenses: Provision for early retirement plan of employees at one of the Israeli manufacturing sites
7. Revaluation of non-cash adjustment related to non-controlling interest: Relates to put options issued to non-controlling interests as part
14
of historical business combinations which took place before January 1, 2010. The put options are presented as a liability at the present value of
the future exercise price. The revaluation of these put options in Solutions is recognized under IFRS to Goodwill, but due to the acquisition of
Solutions by the Company in 2017, which is treated from an accounting perspective as a “Business Combination Under Common Control”,
such revaluation is recorded as a profit or loss item in the financial reports of the Company. The revaluations of such put options have no
bearing on the ongoing performance of the Company and are therefore adjusted for.
15
Exchange Rate Data for the Company's Principal Functional
Currencies
March 31 Q1 Average
2020 2019 Change 2020 2019 Change
EUR/USD 1.094 1.123 (2.6%) 1.102 1.136 (3.0%)
USD/BRL 5.199 3.897 (33.4%) 4.458 3.771 (18.2%)
USD/PLN 4.147 3.837 (8.1%) 3.920 3.790 (3.4%)
USD/ZAR 17.89 14.64 (22.2%) 15.351 14.018 (9.5%)
AUD/USD 0.609 0.708 (14.0%) 0.658 0.713 (7.7%)
GBP/USD 1.234 1.303 (5.3%) 1.234 1.302 (5.3%)
USD/ILS 3.565 3.632 1.8% 3.565 3.644 2.2%
USD LIBOR 3M 1.45% 2.60% (44.2%) 1.53% 2.69% (43.1%)
March 31 Q1 Average
2020 2019 Change 2020 2019 Change
USD/RMB 7.085 6.734 5.2% 6.974 6.744 3.4%
EUR/RMB 7.751 7.561 2.5% 7.687 7.660 0.3%
RMB/BRL 0.734 0.579 (26.8%) 0.639 0.559 (14.3%)
RMB/PLN 0.585 0.570 (2.7%) 0.562 0.562 (0.0%)
RMB/ZAR 2.525 2.174 (16.1%) 2.201 2.079 (5.9%)
AUD/RMB 4.317 4.770 (9.5%) 4.586 4.806 (4.6%)
GBP/RMB 8.742 8.774 (0.4%) 8.926 8.784 1.6%
RMB/ILS 0.503 0.539 6.7% 0.501 0.540 7.2%
16
